ANI Pharmaceuticals Inc's unique product portfolio and manufacturing capabilities position it as a competitive player in the niche markets of hormone therapies
PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) ( ANIP) today announced that following final approval from t
Overview of the Recent Transaction On September 30, 2024, Velan Capital Investment Management LP (Trades, Portfolio) executed a significant transaction by acqui
Overview of Recent Transaction by Stonepine Capital Management, LLC (Trades, Portfolio) On October 23, 2024, Stonepine Capital Management, LLC (Trades, Portfoli
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final...
PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final...
Loading... Loading...
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.80...
The global dry age-related macular degeneration market size was valued at USD 1,589.52 million in 2022. It is expected to reach USD 3,193.53 million by...